Literature DB >> 22131415

Synaptic stimulation of mTOR is mediated by Wnt signaling and regulation of glycogen synthetase kinase-3.

Tao Ma1, Nikos Tzavaras, Panayiotis Tsokas, Emmanuel M Landau, Robert D Blitzer.   

Abstract

The persistent or "late" phase of long-term potentiation (L-LTP), which requires protein synthesis, can be induced by relatively intense synaptic activity. The ability of such strong synaptic protocols to engage the translational machinery and produce plasticity-related proteins, while weaker protocols activate only posttranslational processes and transient potentiation (early LTP; E-LTP), is not understood. Among the major translation control pathways in neurons, the stimulation of mammalian target of rapamycin (mTOR) is a key event in the induction of L-LTP. We report that mTOR is tonically suppressed in rat hippocampus under resting conditions, a consequence of the basal activity of glycogen synthetase kinase 3 (GSK3). This suppression could be overcome by weak synaptic stimulation in the presence of the β-adrenergic agonist isoproterenol, a combination that induced L-LTP, and activation of mTOR coincided with the Akt-mediated phosphorylation of GSK3. Surprisingly, while isoproterenol alone elevated Akt activity, it failed to increase GSK3 phosphorylation or mTOR signaling, showing that Akt was uncoupled from these effectors in the absence of synaptic stimulation. With the addition of weak stimulation, Akt signaled to GSK3 and mTOR, a gating effect that was mediated by voltage-dependent Ca(2+) channels and the Wnt pathway. mTOR could be stimulated by pharmacological inhibition, enabling weak HFS to induce L-LTP. These results establish GSK3 as an integrator of Akt and Wnt signals and suggest that overcoming GSK3-mediated suppression of mTOR is a key event in the induction of L-LTP by synaptic activity.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22131415      PMCID: PMC6623829          DOI: 10.1523/JNEUROSCI.4761-11.2011

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  39 in total

1.  Spatial learning deficit in transgenic mice that conditionally over-express GSK-3beta in the brain but do not form tau filaments.

Authors:  Félix Hernández; José Borrell; Carmen Guaza; Jesús Avila; José J Lucas
Journal:  J Neurochem       Date:  2002-12       Impact factor: 5.372

2.  Protein kinase modulation of dendritic K+ channels in hippocampus involves a mitogen-activated protein kinase pathway.

Authors:  Li-Lian Yuan; J Paige Adams; Michael Swank; J David Sweatt; Daniel Johnston
Journal:  J Neurosci       Date:  2002-06-15       Impact factor: 6.167

Review 3.  The Wnt signaling pathway in development and disease.

Authors:  Catriona Y Logan; Roel Nusse
Journal:  Annu Rev Cell Dev Biol       Date:  2004       Impact factor: 13.827

4.  FKBP12-rapamycin-associated protein (FRAP) autophosphorylates at serine 2481 under translationally repressive conditions.

Authors:  R T Peterson; P A Beal; M J Comb; S L Schreiber
Journal:  J Biol Chem       Date:  2000-03-10       Impact factor: 5.157

5.  Local protein synthesis mediates a rapid increase in dendritic elongation factor 1A after induction of late long-term potentiation.

Authors:  Panayiotis Tsokas; Elizabeth A Grace; Pokman Chan; Tao Ma; Stuart C Sealfon; Ravi Iyengar; Emmanuel M Landau; Robert D Blitzer
Journal:  J Neurosci       Date:  2005-06-15       Impact factor: 6.167

6.  A phosphoserine-regulated docking site in the protein kinase RSK2 that recruits and activates PDK1.

Authors:  M Frödin; C J Jensen; K Merienne; S Gammeltoft
Journal:  EMBO J       Date:  2000-06-15       Impact factor: 11.598

7.  Facilitation of L-type Ca2+ channels in dendritic spines by activation of beta2 adrenergic receptors.

Authors:  Tycho M Hoogland; Peter Saggau
Journal:  J Neurosci       Date:  2004-09-29       Impact factor: 6.167

8.  Unique roles of SK and Kv4.2 potassium channels in dendritic integration.

Authors:  Xiang Cai; Conrad W Liang; Sukumaran Muralidharan; Sukuman Muralidharan; Joseph P Y Kao; Cha-Min Tang; Scott M Thompson
Journal:  Neuron       Date:  2004-10-14       Impact factor: 17.173

9.  Muscarinic receptor-mediated activation of p70 S6 kinase 1 (S6K1) in 1321N1 astrocytoma cells: permissive role of phosphoinositide 3-kinase.

Authors:  Xiuwen Tang; Lijun Wang; Christopher G Proud; C Peter Downes
Journal:  Biochem J       Date:  2003-08-15       Impact factor: 3.857

10.  Time-restricted role for dendritic activation of the mTOR-p70S6K pathway in the induction of late-phase long-term potentiation in the CA1.

Authors:  Maurizio Cammalleri; Robert Lütjens; Fulvia Berton; Alvin R King; Cindy Simpson; Walter Francesconi; Pietro Paolo Sanna
Journal:  Proc Natl Acad Sci U S A       Date:  2003-11-17       Impact factor: 11.205

View more
  36 in total

1.  Cortical astroglia undergo transcriptomic dysregulation in the G93A SOD1 ALS mouse model.

Authors:  Sean J Miller; Jenna C Glatzer; Yi-Chun Hsieh; Jeffrey D Rothstein
Journal:  J Neurogenet       Date:  2018-11-06       Impact factor: 1.250

Review 2.  Therapeutic Potential of Glucagon-Like Peptide-1 Cleavage Product for Alzheimer's Disease.

Authors:  Stephen M Day; Tao Ma
Journal:  Neurosci Bull       Date:  2019-03-07       Impact factor: 5.203

Review 3.  Therapeutic Potential of AMP-Activated Protein Kinase in Alzheimer's Disease.

Authors:  Xin Wang; Helena R Zimmermann; Tao Ma
Journal:  J Alzheimers Dis       Date:  2019       Impact factor: 4.472

Review 4.  Activation of mammalian target of rapamycin and synaptogenesis: role in the actions of rapid-acting antidepressants.

Authors:  Jason M Dwyer; Ronald S Duman
Journal:  Biol Psychiatry       Date:  2013-01-04       Impact factor: 13.382

5.  Glucagon-like peptide-1 cleavage product GLP-1 (9-36) amide enhances hippocampal long-term synaptic plasticity in correlation with suppression of Kv4.2 expression and eEF2 phosphorylation.

Authors:  Stephen M Day; Wenzhong Yang; Sarah Ewin; Xueyan Zhou; Tao Ma
Journal:  Hippocampus       Date:  2017-08-30       Impact factor: 3.899

6.  Glucagon-like peptide-1 cleavage product GLP-1(9-36) amide rescues synaptic plasticity and memory deficits in Alzheimer's disease model mice.

Authors:  Tao Ma; Xueliang Du; Joseph E Pick; Guangzhi Sui; Michael Brownlee; Eric Klann
Journal:  J Neurosci       Date:  2012-10-03       Impact factor: 6.167

7.  Blockade of Tau hyperphosphorylation and Aβ₁₋₄₂ generation by the aminotetrahydrofuran derivative ANAVEX2-73, a mixed muscarinic and σ₁ receptor agonist, in a nontransgenic mouse model of Alzheimer's disease.

Authors:  Valentine Lahmy; Johann Meunier; Susanna Malmström; Gaelle Naert; Laurent Givalois; Seung Hyun Kim; Vanessa Villard; Alexandre Vamvakides; Tangui Maurice
Journal:  Neuropsychopharmacology       Date:  2013-03-14       Impact factor: 7.853

8.  Axonal translation of β-catenin regulates synaptic vesicle dynamics.

Authors:  Anne Marion Taylor; Jason Wu; Hwan-Ching Tai; Erin M Schuman
Journal:  J Neurosci       Date:  2013-03-27       Impact factor: 6.167

9.  Sustained interleukin-1β overexpression exacerbates tau pathology despite reduced amyloid burden in an Alzheimer's mouse model.

Authors:  Simantini Ghosh; Michael D Wu; Solomon S Shaftel; Stephanos Kyrkanides; Frank M LaFerla; John A Olschowka; M Kerry O'Banion
Journal:  J Neurosci       Date:  2013-03-13       Impact factor: 6.167

Review 10.  Synaptic activity-regulated Wnt signaling in synaptic plasticity, glial function and chronic pain.

Authors:  Shao-Jun Tang
Journal:  CNS Neurol Disord Drug Targets       Date:  2014       Impact factor: 4.388

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.